Cart
sales@molnova.com
NCGC00378430
CAS No. 920650-00-6
NCGC00378430( —— )
Catalog No. M24968 CAS No. 920650-00-6
NCGC00378430 is a potent SIX1/EYA2 interaction inhibitor that disrupts the SIX1/EYA2 complex, EMT, and Metastasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 102 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 264 | In Stock |
|
| 50MG | 372 | In Stock |
|
| 100MG | 518 | In Stock |
|
| 200MG | 705 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNCGC00378430
-
NoteResearch use only, not for human use.
-
Brief DescriptionNCGC00378430 is a potent SIX1/EYA2 interaction inhibitor that disrupts the SIX1/EYA2 complex, EMT, and Metastasis.
-
DescriptionNCGC00378430 is a potent SIX1/EYA2 interaction inhibitor that disrupts the SIX1/EYA2 complex, EMT, and Metastasis.
-
In VitroWestern Blot Analysis Cell Line:T47D cells Concentration:20 μM Incubation Time:3 days Result:Blocked TGF-β induced activation of p-Smad3, upregulation of FN1, and downregulation of E-CAD.
-
In VivoAnimal Model:6-8 week old NSG mice with MCF7 tumor cellsDosage:25 mg/kg Administration:Local Injection to the site of tumor; every other day; from day 3 until the day 21 Result:Dramatically decreased distant metastatic burden compared to vehicle treatment.Had no growth inhibitory effect.Animal Model:Mice Dosage:20 mg/kg (Pharmacokinetic Analysis) Administration:IV Result:Had a T1/2α of 0.25 hours, a CL of 6.19 L/hr?kg, a Vss of 4.08 L/kg, a Cmax of 6703 ng/mL and an AUC of 3234 ng/mL?hr.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSIX1-EYA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number920650-00-6
-
Formula Weight441.5
-
Molecular FormulaC22H23N3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:90 mg/mL?(203.85 mM;?Need ultrasonic)
-
SMILESO=C(NC1=CC=C(OC)C(S(=O)(N2CCOCC2)=O)=C1)C3=CC=CC(N4C=CC=C4)=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Amyloid β-Protein (4...
Amyloid β-Protein (4-42) is aAβ Fragment.
-
Balsalazide
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.
-
Tibesaikosaponin V
Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.
